CALGARY,
AB, Feb. 6, 2024 /CNW/ - Nanalysis Scientific
Corp. ("the Company" or "Nanalysis", TSXV: NSCI, OTCQX: NSCIF,
FRA: 1N1), a leader in portable NMR machines, MRI technology for
industrial and research applications, and detection equipment
services, provides an estimate of Q4 2023 unaudited revenue and
highlights some other recent business accomplishments.
Sean Krakiwsky, Founder and
CEO of Nanalysis, states: "We are very pleased with how the
fourth quarter closed out 2023, a year not without its challenges.
While our Security Services business continued its ramp through the
end of the year, we also had strong results in our benchtop
sales that we expect to continue into the first quarter. With both
Benchtop NMR and Security Services contributing significantly, we
were able to achieve fourth quarter unaudited revenues of between
$9.3MM and $9.8MM, constituting a new record quarter for
Nanalysis."1
_________________________________
1 All figures and results referenced in this press
release are preliminary and unaudited
|
"We feel that with the continued trajectory of the Company's
airport security maintenance project, returning strength to
Benchtop NMR revenue, and our cost cutting measures that were
implemented last year and continuing into 2024, we are making
progress toward our corporate objective of generating positive
EBITDA in this fiscal year."
Financial and Operational Highlights:
- New Quarterly Revenue Record: Q4 2023 revenue will
be at least $9.3MM (unaudited),
driven by continued expansion of security services related to the
Company's airport security maintenance project, as well as
continued recovery in Benchtop NMR sales.
- Phase-In of the Company's Airport Security Maintenance
Project: On January 11, 2024, the
Company completed the phase-in period related to its airport
security maintenance project, resulting in the Company's Security
Services business now performing maintenance of passenger screening
imaging and detection equipment across all of Canada. We are confident that the highly
capable team we've built during this project will provide
significant growth opportunities for this business with new
customers and partners.
- 100 MHz Benchtop NMR Product: In Q4, the Company
sold and shipped 14 100MHz Benchtop NMR units, the highest number
of shipments for 100 MHz units in a quarter since the Company
cleared its backlog in 2022. This drove continued recovery in
Benchtop NMR revenue. Customer satisfaction is high, and we
continue to seek value added partnerships and new software
applications to drive more growth.
- New Patent Grant: The Company expanded its patent
portfolio with the grant of United States Patent #US 11,815,574B2
which is part of the ongoing patent pipeline for its Benchtop NMR
products. The Company continues to innovate in several areas of
magnetic resonance technology, and we are proud of this recent
patent grant directly associated with the 100 MHz product.
About Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF,
FRA: 1N1)
Nanalysis Scientific Corp. operates two primary businesses:
Scientific Equipment and Security Services. Within its Scientific
Equipment business is what the Company terms "MRI and NMR for
industry". The Company develops and manufactures portable Nuclear
Magnetic Resonance (NMR) spectrometers or analyzers for laboratory
and industrial markets. The NMReady-60™ was the first full-feature
portable NMR spectrometer in a single compact enclosure requiring
no liquid helium or any other cryogens. The Company has followed-up
that initial offering with new products and continues to have a
strong innovation pipeline. In 2020, the Company announced the
launch of its 100MHz device, the most powerful and most advanced
compact NMR device ever brought to market.
The Company's devices are used in many industries (oil and gas,
chemical, mining, pharma, biotech, flavor and fragrances,
agrochemicals, law enforcement, and more) as well as numerous
government and university research labs around the world. The
Company continues to exploit new global market opportunities
independently and with partners. With its partners, the Company
provides scientific equipment sales and maintenance services
globally.
In 2022, through its subsidiary KPrime, the Company was awarded
a five-year, $160 million contract
with the Government of Canada to
provide maintenance services for passenger screening equipment in
Canadian airports. This has resulted in the expansion of the
Company's Security Services business. The Company is providing
airport security equipment maintenance services for the Government
of Canada in each province and
territory of Canada. In addition,
the Company provides commercial security equipment installation and
maintenance services to a variety of customers in North America.
Notice regarding Forward Looking Statements and Legal
Disclaimer
This news release contains certain "forward-looking statements"
within the meaning of such statements under applicable securities
law. Forward-looking statements are frequently characterized by
words such as "anticipates", "plan", "continue", "expect",
"project", "intend", "believe", "anticipate", "estimate", "may",
"will", "potential", "proposed", "positioned" and other similar
words, or statements that certain events or conditions "may" or
"will" occur. These statements are only predictions. Various
assumptions were used in drawing the conclusions or making the
projections contained in the forward-looking statements throughout
this news release. Forward-looking statements are based on the
opinions and estimates of management at the date the statements are
made and are subject to a variety of risks and uncertainties and
other factors that could cause actual events or results to differ
materially from those projected in the forward-looking statements.
The Company is under no obligation, and expressly disclaims any
intention or obligation, to update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise, except as expressly required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services
Provider accepts responsibility for the adequacy or accuracy of
this release.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/nanalysis-achieves-record-revenue-in-q4-302054258.html
SOURCE Nanalysis Scientific Corp.